BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21844718)

  • 1. Will chlamydia screening reach young people in deprived areas in England? Baseline analysis of the English National Chlamydia Screening Programme delivery in 2008.
    Sheringham J; Simms I; Riha J; Talebi A; Emmett L; Macintosh M; Raine R
    Sex Transm Dis; 2011 Aug; 38(8):677-84. PubMed ID: 21844718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring inequalities in the National Chlamydia Screening Programme in England: added value of ACORN, a commercial geodemographic classification tool.
    Sheringham J; Sowden S; Stafford M; Simms I; Raine R
    Sex Health; 2009 Mar; 6(1):57-62. PubMed ID: 19254493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening.
    LaMontagne DS; Fenton KA; Randall S; Anderson S; Carter P
    Sex Transm Infect; 2004 Oct; 80(5):335-41. PubMed ID: 15459399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Internet testing for Chlamydia trachomatis in England, 2006 to 2010.
    Woodhall SC; Sile B; Talebi A; Nardone A; Baraitser P
    BMC Public Health; 2012 Dec; 12():1095. PubMed ID: 23253518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for gonorrhoea using samples collected through the English national chlamydia screening programme and risk of false positives: a national survey of local authorities.
    Field N; Kennedy I; Folkard K; Duffell S; Town K; Ison CA; Hughes G
    BMJ Open; 2014 Oct; 4(10):e006067. PubMed ID: 25324326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlamydia screening in England: a qualitative study of the narrative behind the policy.
    Sheringham J; Baraitser P; Simms I; Hart G; Raine R
    BMC Public Health; 2012 Apr; 12():317. PubMed ID: 22545922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Who is being tested by the English National Chlamydia Screening Programme? A comparison with national probability survey data.
    Riha J; Mercer CH; Soldan K; French CE; Macintosh M
    Sex Transm Infect; 2011 Jun; 87(4):306-11. PubMed ID: 21429897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in chlamydia prevalence and duration of infection estimated from testing and diagnosis rates in England: a model-based analysis using surveillance data, 2000-15.
    Lewis J; White PJ
    Lancet Public Health; 2018 Jun; 3(6):e271-e278. PubMed ID: 29776798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do sexual health campaigns work? An outcome evaluation of a media campaign to increase chlamydia testing among young people aged 15-24 in England.
    Gobin M; Verlander N; Maurici C; Bone A; Nardone A
    BMC Public Health; 2013 May; 13():484. PubMed ID: 23683345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The implementation of chlamydia screening: a cross-sectional study in the south east of England.
    Johnson SA; Simms I; Sheringham J; Bickler G; Bennett CM; Hall R; Cassell JA
    Sex Transm Infect; 2010 Jun; 86(3):217-21. PubMed ID: 20460264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The English National Chlamydia Screening Programme: variations in positivity in 2007/2008.
    Simms I; Talebi A; Rhia J; Horner P; French RS; Sarah R; Macintosh M
    Sex Transm Dis; 2009 Aug; 36(8):522-7. PubMed ID: 19455079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia diagnosis rate in England in 2012: an ecological study of local authorities.
    Chandrasekaran L; Davies B; Eaton JW; Ward H
    Sex Transm Infect; 2017 May; 93(3):226-228. PubMed ID: 27582249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coverage and uptake of systematic postal screening for genital Chlamydia trachomatis and prevalence of infection in the United Kingdom general population: cross sectional study.
    Macleod J; Salisbury C; Low N; McCarthy A; Sterne JA; Holloway A; Patel R; Sanford E; Morcom A; Horner P; Davey Smith G; Skidmore S; Herring A; Caul O; Hobbs FD; Egger M
    BMJ; 2005 Apr; 330(7497):940. PubMed ID: 15809231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection.
    Low N; McCarthy A; Macleod J; Salisbury C; Campbell R; Roberts TE; Horner P; Skidmore S; Sterne JA; Sanford E; Ibrahim F; Holloway A; Patel R; Barton PM; Robinson SM; Mills N; Graham A; Herring A; Caul EO; Davey Smith G; Hobbs FD; Ross JD; Egger M;
    Health Technol Assess; 2007 Mar; 11(8):iii-iv, ix-xii, 1-165. PubMed ID: 17311735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who is coming back for more chlamydia testing within non-specialist health services and where do they go? England, 2013-2016.
    Harb AK; Town K; Callan E; Furegato M; Connor N; Dunbar JK
    Public Health; 2020 Mar; 180():136-140. PubMed ID: 31901574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the impact: the National Chlamydia Screening Programme.
    Anthonisz M
    Br J Nurs; 2009 Feb 26-Mar 11; 18(4):246-51. PubMed ID: 19462588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using educational outreach and a financial incentive to increase general practices' contribution to chlamydia screening in South-East London 2003-2011.
    Kalwij S; French S; Mugezi R; Baraitser P
    BMC Public Health; 2012 Sep; 12():802. PubMed ID: 22984897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do healthcare professionals and young adults know about the National Chlamydia Screening Programme? Findings from two cross-sectional surveys.
    Currie S; Mercer CH; Dunbar KJ; Saunders J; Woodhall SC
    Int J STD AIDS; 2019 Jan; 30(1):72-78. PubMed ID: 30231833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs and cost effectiveness of different strategies for chlamydia screening and partner notification: an economic and mathematical modelling study.
    Turner K; Adams E; Grant A; Macleod J; Bell G; Clarke J; Horner P
    BMJ; 2011 Jan; 342():c7250. PubMed ID: 21205807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should young people be paid for getting tested? A national comparative study to evaluate patient financial incentives for chlamydia screening.
    Zenner D; Molinar D; Nichols T; Riha J; Macintosh M; Nardone A
    BMC Public Health; 2012 Apr; 12():261. PubMed ID: 22471791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.